Open access · CC-BY
via OpenAlex
Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice
Bo Yang, Kunhuan Yang, Ruitong Xi, Shiying Li, Jingmeng Chen, Yalin Wu
Redox Biology · 2025 · ▲ 13 citations
Abstract
ABSTRACT Dry age-related macular degeneration (AMD) is one of the common blinding eye diseases, with pathological hallmarks of lipofuscin accumulation, neuroretina atrophy and retinal pigment epithelium (RPE) degeneration. Currently, there are no effective interventions for dry AMD. Although there is already evidence suggesting a link between cellular senescence(definition) and age-related diseases, it is still unclear whether long-term senolytic therapy with Dasatinib and Quercetin (D+Q) can slow the progression of dry AMD and ultimately prevent retinal structural damage and function loss. Mice lacking the Abca4 and Rdh8 genes ( Abca4 −/− Rdh8 −/− mice) are a preclinical model of dry AMD. In this study, we performed a 4-month senolytic therapy with D+Q on 4-month-old Abca4 −/− Rdh8 −/− mice. Abca4 −/− Rdh8 −/− mice at the age of 8 months showed obvious retinal degeneration, along with RPE senescence, lysosomal alkalinization, lipofuscin accumulation and oxidative stress. Importantly, the long-term D+Q regimen significantly alleviated the degeneration of retinal structures and function in 8-month-old Abca4 −/− Rdh8 −/− mice, and it effectively repressed cellular senescence, lysosomal alkalinization, lipofuscin accumulation and oxidative stress in the RPE. This study is the first to demonstrate the effect of long-term intervention with senolytics(definition) D+Q on dry AMD. Overall, these findings highlight the potential of long-term senolytic treatment as an intervention for dry AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.redox.2025.103716
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Yang, B., Yang, K., Xi, R., Li, S., Chen, J., & Wu, Y. (2025). Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice. <em>Redox Biology</em>. https://doi.org/10.1016/j.redox.2025.103716
Vancouver
Yang B, Yang K, Xi R, Li S, Chen J, Wu Y. Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice. Redox Biology. 2025. doi:10.1016/j.redox.2025.103716.
BibTeX
@article{bo2025Longte,
title = {Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice},
author = {Bo Yang and Kunhuan Yang and Ruitong Xi and Shiying Li and Jingmeng Chen and Yalin Wu},
journal = {Redox Biology},
year = {2025},
doi = {10.1016/j.redox.2025.103716},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bone Reports 2020
Open access · CC-BY
Senolytic cocktail dasatinib+quercetin (D+Q) ameliorate irradiation-induced bone loss in mice through inhibiting osteocyte senescence and SASP
Antioxidants 2023
Open access · CC-BY
Oxidative Stress and Antioxidants in Age-Related Macular Degeneration
Survey of Ophthalmology 1987
Citation only
Pathophysiology of age-related macular degeneration
Neurobiology of aging 2026
Citation only
Exogenous mitochondrial transplantation attenuates oxidative stress-driven retinal degeneration in a sodium iodate - induced mouse model.
Cells 2021
Open access · CC-BY
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
Antioxidants (Basel, Switzerland) 2026
Open access · OA